Efficacy of brentuximab vedotin in patients with CD30-positive lymphoproliferative skin diseases: results of the first prospective study in the Russian Federation

Background. Primary cutaneous lymphomas are the second most common group of extranodal lymphomas. Unlike nodal lymphomas, where B-cell proliferations dominate, primary cutaneous T-cell lymphomas account for 6575% of all cutaneous lymphomas. Among T-cell lymphomas of the skin, about 50% of cases are...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Irena E. Belousova, Liliya G. Gorenkova, Sergei K. Kravchenko, Alla M. Kovrigina, Elena E. Lepik, Tatiana V. Shneyder
Formato:	Artigo
Idioma:	Inglês
Publicado em:	State Scientific Center of Dermatovenereology and Cosmetology 2022-05-01
coleção:	Vestnik Dermatologii i Venerologii
Assuntos:	primary cutaneous t-cell lymphomas targeted therapy brentuximab vedotin mycosis fungoides lymphomatoid papulosis
Acesso em linha:	https://vestnikdv.ru/jour/article/viewFile/1319/pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!